Следене
Damijan Knez
Damijan Knez
Няма данни за членство
Потвърден имейл адрес: ffa.uni-lj.si
Заглавие
Позовавания
Позовавания
Година
Development of an in-vivo active reversible butyrylcholinesterase inhibitor
U Košak, B Brus, D Knez, R Šink, S Žakelj, J Trontelj, A Pišlar, J Šlenc, ...
Scientific reports 6 (1), 39495, 2016
1602016
The magic of crystal structure-based inhibitor optimization: development of a butyrylcholinesterase inhibitor with picomolar affinity and in vivo activity
U Kosak, B Brus, D Knez, S Zakelj, J Trontelj, A Pislar, R Sink, M Jukic, ...
Journal of medicinal chemistry 61 (1), 119-139, 2018
1572018
Design, synthesis and biological evaluation of new phthalimide and saccharin derivatives with alicyclic amines targeting cholinesterases, beta-secretase and amyloid beta …
D Panek, A Więckowska, T Wichur, M Bajda, J Godyń, J Jończyk, K Mika, ...
European journal of medicinal chemistry 125, 676-695, 2017
962017
Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities
D Knez, N Coquelle, A Pišlar, S Žakelj, M Jukič, M Sova, J Mravljak, ...
European journal of medicinal chemistry 156, 598-617, 2018
932018
LiSiCA: a software for ligand-based virtual screening and its application for the discovery of butyrylcholinesterase inhibitors
S Lešnik, T Štular, B Brus, D Knez, S Gobec, D Janezic, J Konc
Journal of chemical information and modeling 55 (8), 1521-1528, 2015
932015
Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT6 receptor antagonists. Design, synthesis and biological evaluation
A Więckowska, M Kołaczkowski, A Bucki, J Godyń, M Marcinkowska, ...
European journal of medicinal chemistry 124, 63-81, 2016
902016
Tryptophan-derived butyrylcholinesterase inhibitors as promising leads against Alzheimer's disease
A Meden, D Knez, M Jukič, X Brazzolotto, M Gršič, A Pišlar, A Zahirović, ...
Chemical Communications 55 (26), 3765-3768, 2019
872019
N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: Potential multifunctional anti-Alzheimer’s agents
U Košak, D Knez, N Coquelle, B Brus, A Pišlar, F Nachon, X Brazzolotto, ...
Bioorganic & medicinal chemistry 25 (2), 633-645, 2017
712017
Structure-based development of nitroxoline derivatives as potential multifunctional anti-Alzheimer agents
D Knez, B Brus, N Coquelle, I Sosič, R Šink, X Brazzolotto, J Mravljak, ...
Bioorganic & Medicinal Chemistry 23 (15), 4442-4452, 2015
692015
Novel multitarget-directed ligands aiming at symptoms and causes of Alzheimer’s disease
A Wieckowska, T Wichur, J Godyń, A Bucki, M Marcinkowska, A Siwek, ...
ACS chemical neuroscience 9 (5), 1195-1214, 2018
642018
Structure–activity relationships of new cyanothiophene inhibitors of the essential peptidoglycan biosynthesis enzyme MurF
M Hrast, S Turk, I Sosič, D Knez, CP Randall, H Barreteau, ...
European Journal of medicinal chemistry 66, 32-45, 2013
622013
Nonpeptidic selective inhibitors of the chymotrypsin‐like (β5 i) subunit of the immunoproteasome
I Sosič, M Gobec, B Brus, D Knez, M Živec, J Konc, S Lešnik, M Ogrizek, ...
Angewandte Chemie International Edition 55 (19), 5745-5748, 2016
592016
N-alkylpiperidine carbamates as potential anti-Alzheimer’s agents
U Košak, N Strašek, D Knez, M Jukič, S Žakelj, A Zahirović, A Pišlar, ...
European Journal of Medicinal Chemistry 197, 112282, 2020
562020
1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer’s disease
T Wichur, A Więckowska, K Więckowski, J Godyń, J Jończyk, ...
European Journal of Medicinal Chemistry 187, 111916, 2020
552020
Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer’s disease
D Knez, M Sova, U Košak, S Gobec
Future medicinal chemistry 9 (8), 811-832, 2017
522017
Cell models for Alzheimer’s and Parkinson’s disease: At the interface of biology and drug discovery
S Cetin, D Knez, S Gobec, J Kos, A Pišlar
Biomedicine & Pharmacotherapy 149, 112924, 2022
512022
Stereoselective activity of 1-propargyl-4-styrylpiperidine-like analogues that can discriminate between monoamine oxidase isoforms A and B
D Knez, N Colettis, LG Iacovino, M Sova, A Pišlar, J Konc, S Lešnik, ...
Journal of medicinal chemistry 63 (3), 1361-1387, 2020
502020
Design, synthesis, and biological evaluation of 1-benzylamino-2-hydroxyalkyl derivatives as new potential disease-modifying multifunctional anti-Alzheimer’s agents
D Panek, A Wieckowska, J Jonczyk, J Godyn, M Bajda, T Wichur, ...
ACS Chemical Neuroscience 9 (5), 1074-1094, 2018
502018
Design, synthesis, and biological evaluation of 2-(benzylamino-2-hydroxyalkyl) isoindoline-1, 3-diones derivatives as potential disease-modifying multifunctional anti-Alzheimer …
D Panek, A Więckowska, A Pasieka, J Godyń, J Jończyk, M Bajda, D Knez, ...
Molecules 23 (2), 347, 2018
402018
Design, synthesis and evaluation of second generation MurF inhibitors based on a cyanothiophene scaffold
M Hrast, M Anderluh, D Knez, CP Randall, H Barreteau, AJ O'Neill, ...
European Journal of Medicinal Chemistry 73, 83-96, 2014
402014
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20